Pharmacotherapy in the Management of Anxiety and Pain During Acute Coronary Syndromes and the Risk of Developing Symptoms of Posttraumatic Stress Disorder

Roland von Känel, Jean-Paul Schmid, Rebecca E Meister-Langraf, Jürgen Barth, Hansjörg Znoj, Ulrich Schnyder, Mary Princip, Aju P Pazhenkottil, Roland von Känel, Jean-Paul Schmid, Rebecca E Meister-Langraf, Jürgen Barth, Hansjörg Znoj, Ulrich Schnyder, Mary Princip, Aju P Pazhenkottil

Abstract

Background Benzodiazepines and morphine are given during acute coronary syndromes (ACSs) to alleviate anxiety and pain, and β-blockers may also reduce pain. ACS may induce posttraumatic stress disorder (PTSD) symptoms (PTSS). When taken during trauma other than ACS, benzodiazepines increase the risk of PTSS, but it is unknown if benzodiazepines increase the risk of PTSS in ACS. We examined the effects of drug exposure during ACS on the development of PTSS. Methods and Results Study participants were 154 patients with a verified ACS. Baseline demographics, clinical variables, and psychological measures were obtained through a medical history, through a psychometric assessment, and from patient records, and used as covariates in linear regression analysis. Three months after ACS, the severity of PTSS was assessed with the Clinician-Administered PTSD Scale. During ACS, 37.7% of patients were exposed to benzodiazepines, whereas 72.1% were exposed to morphine and 88.3% were exposed to β-blockers, but only 7.1% were exposed to antidepressants. Eighteen (11.7%) patients developed clinical PTSD. Adjusting for all covariates, benzodiazepine use was significantly associated with the Clinician-Administered PTSD Scale total severity score (unstandardized coefficient B [SE], 0.589 [0.274]; partial r=0.18; P=0.032) and the reexperiencing subscore (B [SE], 0.433 [0.217]; partial r=0.17; P=0.047). Patients exposed to benzodiazepines had an almost 4-fold increased relative risk of developing clinical PTSD, adjusting for acute stress disorder symptoms (odds ratio, 3.75; 95% CI, 1.31-10.77). Morphine, β-blockers, and antidepressants showed no predictive value. Conclusions Notwithstanding short-term antianxiety effects during ACS, benzodiazepine use might increase the risk of ACS-induced PTSS with clinical significance, thereby compromising patients' quality of life and prognosis. Registration URL: https://www.clinicaltrials.gov; Unique identifier: NCT01781247.

Keywords: cardiovascular disease; pharmacotherapy; posttraumatic stress disorder; psychological stress; risk factor.

Conflict of interest statement

None.

References

    1. Cassem NH, Hackett TP. Psychiatric consultation in a coronary care unit. Ann Intern Med. 1971;75:9–14.
    1. Moser DK, Riegel B, McKinley S, Doering LV, An K, Sheahan S. Impact of anxiety and perceived control on in‐hospital complications after acute myocardial infarction. Psychosom Med. 2007;69:10–16.
    1. Frazier SK, Moser DK, O'Brien JL, Garvin BJ, An K, Macko M. Management of anxiety after acute myocardial infarction. Heart Lung. 2002;31:411–420.
    1. Moser DK, Dracup K. Is anxiety early after myocardial infarction associated with subsequent ischemic and arrhythmic events? Psychosom Med. 1996;58:395–401.
    1. Grace SL, Abbey SE, Irvine J, Shnek ZM, Stewart DE. Prospective examination of anxiety persistence and its relationship to cardiac symptoms and recurrent cardiac events. Psychother Psychosom. 2004;73:344–352.
    1. Ibanez B, James S, Agewall S, Antunes MJ, Bucciarelli‐Ducci C, Bueno H, Caforio ALP, Crea F, Goudevenos JA, Halvorsen S, et al. 2017 ESC guidelines for the management of acute myocardial infarction in patients presenting with ST‐segment elevation: the Task Force for the management of acute myocardial infarction in patients presenting with ST‐segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2018;39:119–177.
    1. Whitehead DL, Strike P, Perkins‐Porras L, Steptoe A. Frequency of distress and fear of dying during acute coronary syndromes and consequences for adaptation. Am J Cardiol. 2005;96:1512–1516.
    1. Sundström BW, Bång A, Karlsson T, Winge K, Lundberg C, Herlitz J. Anxiolytics in patients suffering a suspected acute coronary syndrome: multi‐centre randomised controlled trial in Emergency Medical Service. Int J Cardiol. 2013;168:3580–3587.
    1. Peacock WF, Hollander JE, Diercks DB, Lopatin M, Fonarow G, Emerman CL. Morphine and outcomes in acute decompensated heart failure: an ADHERE analysis. Emerg Med J. 2008;25:205–209.
    1. Huffman JC, Stern TA. The use of benzodiazepines in the treatment of chest pain: a review of the literature. J Emerg Med. 2003;25:427–437.
    1. Zedigh C, Alho A, Hammar E, Karlsson T, Kellerth T, Svensson L, Grimbrandt E, Herlitz J. Aspects on the intensity and the relief of pain in the prehospital phase of acute coronary syndrome: experiences from a randomized clinical trial. Coron Artery Dis. 2010;21:113–120.
    1. Herlitz J, Bång A, Omerovic E, Wireklint‐Sundström B. Is pre‐hospital treatment of chest pain optimal in acute coronary syndrome? The relief of both pain and anxiety is needed. Int J Cardiol. 2011;149:147–151.
    1. Vilchinsky N, Ginzburg K, Fait K, Foa EB. Cardiac‐disease‐induced PTSD (CDI‐PTSD): a systematic review. Clin Psychol Rev. 2017;55:92–106.
    1. Edmondson D, Richardson S, Falzon L, Davidson KW, Mills MA, Neria Y. Posttraumatic stress disorder prevalence and risk of recurrence in acute coronary syndrome patients: a meta‐analytic review [published correction appears in PLoS One. 2019;14:e0213635]. PLoS One. 2012;7:e38915.
    1. von Känel R, Hari R, Schmid JP, Wiedemar L, Guler E, Barth J, Saner H, Schnyder U, Begré S. Non‐fatal cardiovascular outcome in patients with posttraumatic stress symptoms caused by myocardial infarction. J Cardiol. 2011;58:61–68.
    1. Parker AM, Sricharoenchai T, Raparla S, Schneck KW, Bienvenu OJ, Needham DM. Posttraumatic stress disorder in critical illness survivors: a metaanalysis. Crit Care Med. 2015;43:1121–1129.
    1. Guina J, Rossetter SR, DeRhodes BJ, Nahhas RW, Welton RS. Benzodiazepines for PTSD: a systematic review and meta‐analysis. J Psychiatr Pract. 2015;21:281–303.
    1. Bryant RA, Creamer M, O'Donnell M, Silove D, McFarlane AC. A study of the protective function of acute morphine administration on subsequent posttraumatic stress disorder. Biol Psychiatry. 2009;65:438–440.
    1. Holbrook TL, Galarneau MR, Dye JL, Quinn K, Dougherty AL. Morphine use after combat injury in Iraq and post‐traumatic stress disorder. N Engl J Med. 2010;362:110–117.
    1. Hari R, Begré S, Schmid JP, Saner H, Gander ML, von Känel R. Change over time in posttraumatic stress caused by myocardial infarction and predicting variables. J Psychosom Res. 2010;69:143–150.
    1. Guler E, Schmid JP, Wiedemar L, Saner H, Schnyder U, von Känel R. Clinical diagnosis of posttraumatic stress disorder after myocardial infarction. Clin Cardiol. 2009;32:125–129.
    1. Amos T, Stein DJ, Ipser JC. Pharmacological interventions for preventing post‐traumatic stress disorder (PTSD). Cochrane Database Syst Rev. 2014;7:CD006239.
    1. Astill Wright L, Sijbrandij M, Sinnerton R, Lewis C, Roberts NP, Bisson JI. Pharmacological prevention and early treatment of post‐traumatic stress disorder and acute stress disorder: a systematic review and meta‐analysis. Transl Psychiatry. 2019;9:334.
    1. Meli L, Chang BP, Shimbo D, Swan BW, Edmondson D, Sumner JA. Beta blocker administration during emergency department evaluation for acute coronary syndrome is associated with lower posttraumatic stress symptoms 1‐month later. J Trauma Stress. 2017;30:313–317.
    1. Meister R, Princip M, Schmid JP, Schnyder U, Barth J, Znoj H, Herbert C, von Känel R. Myocardial Infarction ‐ Stress PRevention INTervention (MI‐SPRINT) to reduce the incidence of posttraumatic stress after acute myocardial infarction through trauma‐focused psychological counseling: study protocol for a randomized controlled trial. Trials. 2013;14:329.
    1. von Känel R, Barth J, Princip M, Meister‐Langraf RE, Schmid JP, Znoj H, Herbert C, Schnyder U. Early psychological counseling for the prevention of posttraumatic stress induced by acute coronary syndrome: the MI‐SPRINT randomized controlled trial. Psychother Psychosom. 2018;87:75–84.
    1. von Känel R, Hari R, Schmid JP, Saner H, Begré S. Distress related to myocardial infarction and cardiovascular outcome: a retrospective observational study. BMC Psychiatry. 2011;11:98.
    1. Bopp M, Minder CE; Swiss National Cohort . Mortality by education in German speaking Switzerland, 1990–1997: results from the Swiss National Cohort. Int J Epidemiol. 2003;32:346–354.
    1. Fox KA, Dabbous OH, Goldberg RJ, Pieper KS, Eagle KA, Van de Werf F, Avezum A, Goodman SG, Flather MD, Anderson FA Jr, et al. Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome: prospective multinational observational study (GRACE). BMJ. 2006;333:1091.
    1. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373–383.
    1. Dyer MT, Goldsmith KA, Sharples LS, Buxton MJ. A review of health utilities using the EQ‐5D in studies of cardiovascular disease. Health Qual Life Outcomes. 2010;8:13.
    1. Helfricht S, Landolt MA, Moergeli H, Hepp U, Wegener D, Schnyder U. Psychometric evaluation and validation of the German version of the Acute Stress Disorder Scale across two distinct trauma populations. J Trauma Stress. 2009;22:476–480.
    1. Denollet J. Emotional distress and fatigue in coronary heart disease: the Global Mood Scale (GMS). Psychol Med. 1993;23:111–121.
    1. Schnyder U, Moergeli H. German version of Clinician‐Administered PTSD Scale. J Trauma Stress. 2002;15:487–492.
    1. Blanchard EB, Hickling EJ, Taylor AE, Forneris CA, Loos W, Jaccard J. Effects of varying scoring rules of the Clinician‐Administered PTSD Scale (CAPS) for the diagnosis of post‐traumatic stress disorder in motor vehicle accident victims. Behav Res Ther. 1995;33:471–475.
    1. Wade DM, Howell DC, Weinman JA, Hardy RJ, Mythen MG, Brewin CR, Borja‐Boluda S, Matejowsky CF, Raine RA. Investigating risk factors for psychological morbidity three months after intensive care: a prospective cohort study. Crit Care. 2012;16:R192.
    1. Samuelson KA, Lundberg D, Fridlund B. Stressful memories and psychological distress in adult mechanically ventilated intensive care patients—a 2‐month follow‐up study. Acta Anaesthesiol Scand. 2007;51:671–678.
    1. Girard TD, Shintani AK, Jackson JC, Gordon SM, Pun BT, Henderson MS, Dittus RS, Bernard GR, Ely EW. Risk factors for post‐traumatic stress disorder symptoms following critical illness requiring mechanical ventilation: a prospective cohort study. Crit Care. 2007;11:R28.
    1. Gelpin E, Bonne O, Peri T, Brandes D, Shalev AY. Treatment of recent trauma survivors with benzodiazepines: a prospective study. J Clin Psychiatry. 1996;57:390–394.
    1. Birk JL, Sumner JA, Haerizadeh M, Heyman‐Kantor R, Falzon L, Gonzalez C, Gershengoren L, Shapiro P, Edmondson D, Kronish IM. Early interventions to prevent posttraumatic stress disorder symptoms in survivors of life‐threatening medical events: a systematic review. J Anxiety Disord. 2019;64:24–39.
    1. Edmondson D, Shimbo D, Ye S, Wyer P, Davidson KW. The association of emergency department crowding during treatment for acute coronary syndrome with subsequent posttraumatic stress disorder symptoms. JAMA Intern Med. 2013;173:472–474.
    1. Sijbrandij M, Kleiboer A, Bisson JI, Barbui C, Cuijpers P. Pharmacological prevention of post‐traumatic stress disorder and acute stress disorder: a systematic review and meta‐analysis [published correction appears in Lancet Psychiatry. 2015;2:584]. Lancet Psychiatry. 2015;2:413–421.
    1. Parodi G, Bellandi B, Xanthopoulou I, Capranzano P, Capodanno D, Valenti R, Stavrou K, Migliorini A, Antoniucci D, Tamburino C, et al. Morphine is associated with a delayed activity of oral antiplatelet agents in patients with ST‐elevation acute myocardial infarction undergoing primary percutaneous coronary intervention. Circ Cardiovasc Interv. 2014;8:e001593. DOI: 10.1161/CIRCINTERVENTIONS.114.001593.
    1. Pitman RK, Delahanty DL. Conceptually driven pharmacologic approaches to acute trauma. CNS Spectr. 2005;10:99–106.
    1. Luo Y, Li Z, Tu Q, Xia L. Metoprolol decreases retention of fear memory and facilitates long‐term depression in lateral amygdala. Behav Pharmacol. 2020;31:535–543.
    1. Suliman S, Seedat S, Pingo J, Sutherland T, Zohar J, Stein DJ. Escitalopram in the prevention of posttraumatic stress disorder: a pilot randomized controlled trial. BMC Psychiatry. 2015;15:24.
    1. Shalev AY, Ankri Y, Israeli‐Shalev Y, Peleg T, Adessky R, Freedman S. Prevention of posttraumatic stress disorder by early treatment: results from the Jerusalem Trauma Outreach And Prevention study. Arch Gen Psychiatry. 2012;69:166–176.
    1. Chamberlain AM, Vickers KS, Colligan RC, Weston SA, Rummans TA, Roger VL. Associations of preexisting depression and anxiety with hospitalization in patients with cardiovascular disease. Mayo Clin Proc. 2011;86:1056–1062.

Source: PubMed

Sponsorer og samarbeidspartnere

Medisinsk tilstand

Legemiddelintervensjoner

3
Abonnere